Tokyo, Japan and Cambridge, UK, 8August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter…Read More

You might also be interested in reading Why This Popular Crypto Analyst Bought 1 Million ADA.